OMGA: Omega Therapeutics, Inc. Stock

by  •  • Comments Off on OMGA: Omega Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 33.05
Enterprise Value ($M) 18.26
Book Value ($M) 11.54
Book Value / Share 0.21
Price / Book 2.86
NCAV ($M) -110.81
NCAV / Share -2.00
Price / NCAV -0.30

Profitability (mra)
Return on Invested Capital (ROIC) -0.52
Return on Assets (ROA) -0.36
Return on Equity (ROE) -1.26

Liquidity (mrq)
Quick Ratio 1.26
Current Ratio 1.26

Balance Sheet (mrq) ($M)
Current Assets 30.38
Assets 152.73
Liabilities 141.18
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-12 13G/A Fmr Llc 10.68 11.39
02-09 13G/A HarbourVest Partners L.P. 6.40 32.68

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-15 71,579 155,680 45.98
2025-01-14 99,123 241,503 41.04
2025-01-13 82,633 321,823 25.68
2025-01-10 166,348 400,622 41.52

(click for more detail)

Similar Companies
NXTC – NextCure, Inc. OGI – Organigram Holdings Inc.
OLMA – Olema Pharmaceuticals, Inc. OPK – OPKO Health, Inc.
OPTN – OptiNose, Inc.


Financial data and stock pages provided by
Fintel.io